Agios Pharmaceuticals Ownership | Who Owns Agios Pharmaceuticals?
Agios Pharmaceuticals Ownership Summary
Agios Pharmaceuticals is owned by 104.33% institutional investors, 1.60% insiders. Farallon capital management is the largest institutional shareholder, holding 9.97% of AGIO shares. BB Biotech AG Ord is the top mutual fund, with 6.16% of its assets in Agios Pharmaceuticals shares.
AGIO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Agios Pharmaceuticals | 104.33% | 1.60% | -5.94% |
| Sector | Healthcare Stocks | 279.18% | 10.62% | -189.80% |
| Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Farallon capital management | 5.67M | 9.97% | $186.46M |
| Vanguard group | 5.63M | 9.89% | $185.05M |
| Blackrock funding, inc. /de | 5.02M | 8.81% | $164.83M |
| Blackrock | 4.86M | 8.55% | $209.52M |
| Bellevue group | 3.52M | 6.17% | $115.51M |
| Price t rowe associates inc /md/ | 2.42M | 4.26% | $79.64M |
| Armistice capital | 2.26M | 3.98% | $74.41M |
| State street | 2.15M | 3.78% | $70.72M |
| Macquarie group | 1.68M | 2.96% | $55.37M |
| Geode capital management | 1.35M | 2.37% | $44.36M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Caligan partners lp | 626.28K | 5.21% | $20.58M |
| Cutter capital management, lp | 301.62K | 4.06% | $9.91M |
| Eagle health investments lp | 330.83K | 2.67% | $10.87M |
| Bellevue group | 3.52M | 2.22% | $115.51M |
| Frazier life sciences management | 871.97K | 1.76% | $37.60M |
| Patient square capital lp | 121.73K | 1.50% | $4.00M |
| Armistice capital | 2.26M | 1.02% | $74.41M |
| Farallon capital management | 5.67M | 0.95% | $186.46M |
| Centerbook partners lp | 305.60K | 0.60% | $10.04M |
| Rock springs capital management lp | 471.09K | 0.59% | $15.48M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Frazier life sciences management | 871.97K | 1.76% | 348.81K |
| Adage capital partners gp | 303.00K | 0.02% | 303.00K |
| Deutsche bank ag\ | 935.25K | 0.01% | 265.64K |
| Casdin capital | 250.00K | 0.55% | 250.00K |
| Blackrock | 4.86M | 0.00% | 200.91K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jefferies financial group | - | - | -1.50M |
| Bvf inc/il | - | - | -1.07M |
| T. rowe price investment management | - | - | -928.60K |
| Vestal point capital, lp | - | - | -760.00K |
| Jpmorgan chase | 1.02M | 0.00% | -697.63K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Adage capital partners gp | 303.00K | 0.02% | 303.00K | $9.96M |
| Casdin capital | 250.00K | 0.55% | 250.00K | $8.21M |
| Norges bank | 145.09K | 0.00% | 145.09K | $4.77M |
| Patient square capital lp | 121.73K | 1.50% | 121.73K | $4.00M |
| Gsa capital partners llp | 53.23K | 0.13% | 53.23K | $1.75M |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -1.00 |
| Ifp advisors | -3.00 |
| Nelson, van denburg & campbell wealth management group | -11.00 |
| Riverview trust | -11.00 |
| Covestor | -12.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 223 | -4.29% | 59,949,912 | 0.23% | 104 | 0.95% | 113 | -12.40% | 71 | 2.90% |
| Dec 31, 2024 | 231 | 4.05% | 58,738,591 | 1.40% | 103 | 1.00% | 126 | 22.33% | 70 | 2.94% |
| Sep 30, 2024 | 222 | 1.83% | 57,925,704 | 3.66% | 101 | 1.05% | 104 | 1.96% | 66 | -15.38% |
| Jun 30, 2024 | 218 | 9.00% | 55,883,066 | -6.01% | 98 | 0.88% | 102 | -0.97% | 78 | 39.29% |
| Mar 31, 2024 | 200 | 11.73% | 59,453,348 | 2.90% | 105 | 0.98% | 103 | 9.57% | 56 | 12.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BB Biotech AG Ord | 3.52M | 6.16% | -220.76K |
| Vanguard Total Stock Mkt Idx Inv | 1.84M | 3.17% | 36.57K |
| Vanguard US Total Market Shares ETF | 1.79M | 3.12% | 2.35K |
| Macquarie Small Cap Core I | 1.52M | 2.62% | 43.09K |
| iShares Russell 2000 ETF | 1.45M | 2.51% | 711.00 |
| Vanguard Small Cap Index | 1.44M | 2.49% | 12.48K |
| Delaware Small Cap Core I | 1.38M | 2.42% | -8.55K |
| T. Rowe Price Health Sciences | 1.06M | 1.84% | -56.53K |
| SPDR® S&P Biotech ETF | 1.06M | 1.82% | 1.36K |
| Polar Capital Biotech S Inc | 1.00M | 1.73% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 10, 2025 | FOUSE JACQUALYN A | - | Sell | $194.17K |
| Mar 03, 2025 | Burns James William | Chief Legal Officer | Sell | $40.41K |
| Mar 03, 2025 | Burns James William | Chief Legal Officer | Sell | $42.19K |
| Mar 03, 2025 | Burns James William | Chief Legal Officer | Sell | $59.74K |
| Mar 03, 2025 | Jones Cecilia | Chief Financial Officer | Sell | $59.74K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | 1 |
| 2025 Q1 | - | 16 |
| 2024 Q4 | - | 9 |
| 2024 Q3 | - | 3 |
| 2024 Q2 | - | 3 |
AGIO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools